Drinking straws are one of the tools in columnist Dagmar Munn's arsenal to combat dysphagia while living with ALS.

Altered activity of ancient viral genes were linked to neurodegenerative diseases including ALS in a recent analysis.

Avicenna received a patent covering ROCK inhibitor compounds for ALS, Parkinson’s, and other neurodegenerative conditions.

This content is sponsored by Mitsubishi Tanabe Pharma America, Inc. (MTPA) and is intended for US audiences only. Any other present or future content posted by the contributor, not expressly ...

Long-term treatment with the cell therapy NurOwn was found to significantly extend survival for ALS patients compared with ...

Neurosense Therapeutics will meet with the FDA in early November to discuss plans for a Phase 3 trial to test PrimeC in ALS.